299 related articles for article (PubMed ID: 29709615)
1. Common proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer patients.
Chen M; Lee HK; Moo L; Hanlon E; Stein T; Xia W
J Proteomics; 2018 Jun; 182():21-33. PubMed ID: 29709615
[TBL] [Abstract][Full Text] [Related]
2. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
3. Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells.
Lee HK; Velazquez Sanchez C; Chen M; Morin PJ; Wells JM; Hanlon EB; Xia W
PLoS One; 2016; 11(9):e0163072. PubMed ID: 27684569
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
Giunti E; Collu R; Daley S; Querfurth H; Morin P; Killick R; Melamed RD; Xia W
J Alzheimers Dis; 2023; 96(4):1695-1709. PubMed ID: 38007655
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis.
Pomeshchik Y; Velasquez E; Gil J; Klementieva O; Gidlöf R; Sydoff M; Bagnoli S; Nacmias B; Sorbi S; Westergren-Thorsson G; Gouras GK; Rezeli M; Roybon L
Acta Neuropathol Commun; 2023 Sep; 11(1):150. PubMed ID: 37715247
[TBL] [Abstract][Full Text] [Related]
6. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
7. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
Chen M; Xia W
J Alzheimers Dis; 2020; 76(1):349-368. PubMed ID: 32474469
[TBL] [Abstract][Full Text] [Related]
9. Human Induced Pluripotent Stem Cell-Derived Neural Cells from Alzheimer's Disease Patients Exhibited Different Susceptibility to Oxidative Stress.
Zhang L; Xu M; Ren Q; Liu G; Meng S; Xiahou K; Zhang Y; Jiang N; Zhou W
Stem Cells Dev; 2020 Nov; 29(22):1444-1456. PubMed ID: 32988331
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.
Foveau B; Correia AS; Hébert SS; Rainone S; Potvin O; Kergoat MJ; Belleville S; Duchesne S; LeBlanc AC;
J Alzheimers Dis; 2019; 67(3):893-910. PubMed ID: 30689579
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
12. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons.
Zhang D; Pekkanen-Mattila M; Shahsavani M; Falk A; Teixeira AI; Herland A
Biomaterials; 2014 Feb; 35(5):1420-8. PubMed ID: 24290439
[TBL] [Abstract][Full Text] [Related]
13. iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samples.
Verheijen MCT; Krauskopf J; Caiment F; Nazaruk M; Wen QF; van Herwijnen MHM; Hauser DA; Gajjar M; Verfaillie C; Vermeiren Y; De Deyn PP; Wittens MMJ; Sieben A; Engelborghs S; Dejonckheere W; Princen K; Griffioen G; Roggen EL; Briedé JJ
Toxicol Lett; 2022 Mar; 356():89-99. PubMed ID: 34921933
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
15. Topographic regulation of kinase activity in Alzheimer's disease brains.
Grant P; Pant HC
J Alzheimers Dis; 2002 Aug; 4(4):269-81. PubMed ID: 12446929
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
[TBL] [Abstract][Full Text] [Related]
17. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies.
Pomeshchik Y; Klementieva O; Gil J; Martinsson I; Hansen MG; de Vries T; Sancho-Balsells A; Russ K; Savchenko E; Collin A; Vaz AR; Bagnoli S; Nacmias B; Rampon C; Sorbi S; Brites D; Marko-Varga G; Kokaia Z; Rezeli M; Gouras GK; Roybon L
Stem Cell Reports; 2020 Jul; 15(1):256-273. PubMed ID: 32589876
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.
Balez R; Steiner N; Engel M; Muñoz SS; Lum JS; Wu Y; Wang D; Vallotton P; Sachdev P; O'Connor M; Sidhu K; Münch G; Ooi L
Sci Rep; 2016 Aug; 6():31450. PubMed ID: 27514990
[TBL] [Abstract][Full Text] [Related]
19. A three-dimensional spheroid co-culture system of neurons and astrocytes derived from Alzheimer's disease patients for drug efficacy testing.
Park H; Kim J; Ryou C
Cell Prolif; 2023 Jun; 56(6):e13399. PubMed ID: 36628615
[TBL] [Abstract][Full Text] [Related]
20. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
